Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease.

Jialal, I; Devaraj, S

Jialal, I; Devaraj, S.

Affiliation

Jialal I; Laboratory for Atherosclerosis and Metabolic Research, UC Davis Medical Center, Sacramento, California, USA.
Devaraj S; Baylor College of Medicine, Houston, Texas, USA.

Clin Pharmacol Ther ; 98(2): 121-3, 2015 Aug.

Article in En | MEDLINE | ID: mdl-25732108

Subject(s)

Anti-Inflammatory Agents/therapeutic use; Cardiovascular Diseases/prevention & control; Diabetes Mellitus/drug therapy; Diabetic Angiopathies/prevention & control; Inflammation Mediators/antagonists & inhibitors; Animals; Cardiovascular Diseases/diagnosis; Cardiovascular Diseases/immunology; Cardiovascular Diseases/metabolism; Diabetes Mellitus/diagnosis; Diabetes Mellitus/immunology; Diabetes Mellitus/metabolism; Diabetic Angiopathies/diagnosis; Diabetic Angiopathies/immunology; Diabetic Angiopathies/metabolism; Humans; Inflammation Mediators/metabolism; Risk Assessment; Risk Factors; Signal Transduction/drug effects; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Inflammation Mediators / Diabetes Mellitus / Diabetic Angiopathies / Anti-Inflammatory Agents Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Clin Pharmacol Ther Year: 2015 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google